Winnergy Medical PCL
SET:WINMED
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its Industry Average (17.1), the stock would be worth ฿-0.33 (138% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -45.3 | ฿0.88 |
0%
|
| Industry Average | 17.1 | ฿-0.33 |
-138%
|
| Country Average | 13.4 | ฿-0.26 |
-130%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| TH |
W
|
Winnergy Medical PCL
SET:WINMED
|
352m THB | -45.3 | 23.2 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
101.2B USD | 12.4 | 22.8 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
60.7B USD | 20.2 | 37.4 | |
| US |
|
Cencora Inc
NYSE:COR
|
60.6B USD | 19.7 | 36.4 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
47.9B USD | 6.7 | 27.2 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
32B AUD | 40.5 | 35.2 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
62.8B CNY | 21.4 | 11 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
58.8B CNY | 136.9 | 20.7 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.5B USD | 8.9 | 21.5 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | -236.8 | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
58.6B HKD | -35.7 | 7.2 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 8.8 |
| Median | 13.4 |
| 70th Percentile | 20 |
| Max | 1 747 |
Other Multiples
Winnergy Medical PCL
Glance View
Winnergy Medical PCL engages in distribution of medical equipment. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2021-05-11. The firm imports high technology medical and diagnostic products from around the world to help improve the lives of people in Thailand. The firm operates through two segments: Revenue from medical products and Revenue from other products. The firm's businesses include trading business and WINMED Laboratory Services. Its trading business includes women healthcare, blood banking, blood safety, cell therapy and other businesses. The firm imports products for cervical cancer detection and surgical gynecology from Hologic Company of the United States. The firm imports products related to blood donation from Haemonetics Company of the United States. The company distributes blood infection test products from Grifols of Spain. The firm imports stem cell and contamination analysis products with specimens from Germany's Miltenyi Biotec.
